首页 > 最新文献

Postepy W Kardiologii Interwencyjnej最新文献

英文 中文
Plasma levels of NO-related pathway molecules to predict post-transcatheter aortic valve implantation major adverse cardiovascular events: a prospective, multicenter study. 血浆no相关途径分子水平预测经导管主动脉瓣植入术后主要不良心血管事件:一项前瞻性、多中心研究
IF 1.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-06-04 eCollection Date: 2025-06-01 DOI: 10.5114/aic.2025.151798
Aleksandra Gąsecka, Natalia Krajewska, Bogna Rajewska, Agata Suleja, Weronika Kisielewska, Michał Łomiak, Jan Budzianowski, Anna Olasińska-Wiśniewska, Janusz Kochman, Marcin Ufnal

Introduction: Aortic stenosis (AS) is associated with alterations in the concentrations of nitric oxide (NO)-related pathway molecules, including arginine, asymmetric dimethylarginine (ADMA), and symmetric dimethylarginine (SDMA).

Aim: We aimed to determine the effect of transcatheter aortic valve implantation (TAVI) on the concentrations of arginine, ADMA, and SDMA and to evaluate their predictive value for post-TAVI outcomes.

Material and methods: In total, 128 patients with AS referred for TAVI were enrolled in the study. Blood samples were collected 1 day before TAVI and at hospital discharge. Concentrations of arginine, ADMA, and SDMA were measured using ultra performance liquid chromatography coupled with mass spectrometry.

Results: Plasma concentrations of arginine, ADMA, and SDMA did not change after TAVI, compared to baseline (p ≥ 0.70 for all). The median time of follow-up was 13.5 months. Arginine, ADMA, and SDMA did not predict post-TAVI MACE during the follow-up time (p ≥ 0.88). There were significant negative correlations between the concentrations of ADMA and SDMA and echocardiographic parameters of AS severity before TAVI (p < 0.01 for all).

Conclusions: Plasma concentrations of arginine, ADMA, and SDMA were not affected by TAVI and did not predict post-TAVI MACE. ADMA and SDMA negatively correlated with AS severity, which might indicate alterations in the NO/L-arginine pathway in patients with AS.

主动脉瓣狭窄(Aortic stenosis, AS)与一氧化氮(NO)相关通路分子的浓度改变有关,包括精氨酸、不对称二甲基精氨酸(ADMA)和对称二甲基精氨酸(SDMA)。目的:我们旨在确定经导管主动脉瓣植入术(TAVI)对精氨酸、ADMA和SDMA浓度的影响,并评估其对TAVI后预后的预测价值。材料和方法:共有128例AS患者被纳入TAVI研究。在TAVI前1天和出院时采集血样。采用超高效液相色谱联用质谱法测定精氨酸、ADMA和SDMA的浓度。结果:与基线相比,TAVI后血浆精氨酸、ADMA和SDMA浓度未发生变化(p≥0.70)。中位随访时间为13.5个月。在随访期间,精氨酸、ADMA和SDMA不能预测tavi后MACE (p≥0.88)。TAVI前ADMA、SDMA浓度与AS严重程度超声心动图参数呈显著负相关(p < 0.01)。结论:血浆精氨酸、ADMA和SDMA浓度不受TAVI的影响,也不能预测TAVI后的MACE。ADMA和SDMA与AS严重程度呈负相关,这可能提示AS患者NO/ l -精氨酸通路的改变。
{"title":"Plasma levels of NO-related pathway molecules to predict post-transcatheter aortic valve implantation major adverse cardiovascular events: a prospective, multicenter study.","authors":"Aleksandra Gąsecka, Natalia Krajewska, Bogna Rajewska, Agata Suleja, Weronika Kisielewska, Michał Łomiak, Jan Budzianowski, Anna Olasińska-Wiśniewska, Janusz Kochman, Marcin Ufnal","doi":"10.5114/aic.2025.151798","DOIUrl":"10.5114/aic.2025.151798","url":null,"abstract":"<p><strong>Introduction: </strong>Aortic stenosis (AS) is associated with alterations in the concentrations of nitric oxide (NO)-related pathway molecules, including arginine, asymmetric dimethylarginine (ADMA), and symmetric dimethylarginine (SDMA).</p><p><strong>Aim: </strong>We aimed to determine the effect of transcatheter aortic valve implantation (TAVI) on the concentrations of arginine, ADMA, and SDMA and to evaluate their predictive value for post-TAVI outcomes.</p><p><strong>Material and methods: </strong>In total, 128 patients with AS referred for TAVI were enrolled in the study. Blood samples were collected 1 day before TAVI and at hospital discharge. Concentrations of arginine, ADMA, and SDMA were measured using ultra performance liquid chromatography coupled with mass spectrometry.</p><p><strong>Results: </strong>Plasma concentrations of arginine, ADMA, and SDMA did not change after TAVI, compared to baseline (<i>p</i> ≥ 0.70 for all). The median time of follow-up was 13.5 months. Arginine, ADMA, and SDMA did not predict post-TAVI MACE during the follow-up time (<i>p</i> ≥ 0.88). There were significant negative correlations between the concentrations of ADMA and SDMA and echocardiographic parameters of AS severity before TAVI (<i>p</i> < 0.01 for all).</p><p><strong>Conclusions: </strong>Plasma concentrations of arginine, ADMA, and SDMA were not affected by TAVI and did not predict post-TAVI MACE. ADMA and SDMA negatively correlated with AS severity, which might indicate alterations in the NO/L-arginine pathway in patients with AS.</p>","PeriodicalId":49678,"journal":{"name":"Postepy W Kardiologii Interwencyjnej","volume":"21 2","pages":"211-220"},"PeriodicalIF":1.5,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12244343/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144627575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neutrophil-to-lymphocyte ratio as a predictor of left ventricle function and mortality in patients with myocardial infarction. 中性粒细胞与淋巴细胞比值作为心肌梗死患者左心室功能和死亡率的预测因子。
IF 1.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-05-31 eCollection Date: 2025-06-01 DOI: 10.5114/aic.2025.151724
Michał Węgiel, Kinga Glądys, Barbara Zdzierak, Artur Dziewierz, Stanisław Bartuś, Tomasz Rakowski

Introduction: Myocardial infarction (MI) is a complex clinical syndrome that significantly influences long-term outcomes through its effects on myocardial remodeling, heart failure progression, and mortality. Despite extensive research, there is still no consensus regarding optimal biomarkers for risk stratification of MI patients in terms of long-term outcomes.

Aim: The study aimed to assess neutrophil-to-lymphocyte ratio (NLR) and evaluate the association between this ratio and long-term clinical and echocardiographic outcomes in patients hospitalized for MI.

Material and methods: A total of 412 patients hospitalized for MI between 2016 and 2019 were screened. Demographic data, baseline clinical characteristics, typical biochemical parameters, and angiographic and echocardiographic findings were analyzed. Patients underwent long-term clinical and echocardiographic follow-up.

Results: NLR correlated negatively with both baseline and follow-up left ventricular ejection fraction (LVEF) (r = -0.214; p = 0.043 and r = -0.3; p < 0.001, respectively). In regression analysis, NLR was a significant predictor of long-term reduced LVEF (defined as a value < 40%) (OR = 4.01; p < 0.001) as well as all-cause mortality (OR = 1.16; p = 0.008). In receiver operating characteristic (ROC) analysis, NLR demonstrated significant predictive value for mortality (AUC = 0.65; p = 0.04) with an optimal cut-off point of 8.7 (Youden index = 0.4). Kaplan-Meier analysis revealed that patients with NLR > 8.7 had significantly poorer survival compared to those with lower NLR values (p < 0.001).

Conclusions: Elevated NLR was associated with poorer left ventricular function and increased mortality in patients after MI during long-term observation.

心肌梗死(MI)是一种复杂的临床综合征,通过其对心肌重塑、心力衰竭进展和死亡率的影响,显著影响长期预后。尽管进行了广泛的研究,但就长期预后而言,对于心肌梗死患者风险分层的最佳生物标志物仍未达成共识。目的:本研究旨在评估中性粒细胞与淋巴细胞比率(NLR),并评估该比率与心肌梗死住院患者长期临床和超声心动图结果的关系。材料和方法:2016 - 2019年共筛选412例心肌梗死住院患者。统计资料、基线临床特征、典型生化参数、血管造影和超声心动图结果进行分析。患者接受了长期的临床和超声心动图随访。结果:NLR与基线和随访左室射血分数(LVEF)呈负相关(r = -0.214;P = 0.043, r = -0.3;P < 0.001)。在回归分析中,NLR是LVEF长期降低(定义为值< 40%)的显著预测因子(OR = 4.01;p < 0.001)以及全因死亡率(OR = 1.16;P = 0.008)。在受试者工作特征(ROC)分析中,NLR对死亡率具有显著的预测价值(AUC = 0.65;p = 0.04),最佳分界点为8.7(约登指数= 0.4)。Kaplan-Meier分析显示,NLR值为bb0 8.7的患者的生存期明显低于NLR值较低的患者(p < 0.001)。结论:在长期观察中,心肌梗死患者NLR升高与左心室功能变差和死亡率增加有关。
{"title":"Neutrophil-to-lymphocyte ratio as a predictor of left ventricle function and mortality in patients with myocardial infarction.","authors":"Michał Węgiel, Kinga Glądys, Barbara Zdzierak, Artur Dziewierz, Stanisław Bartuś, Tomasz Rakowski","doi":"10.5114/aic.2025.151724","DOIUrl":"10.5114/aic.2025.151724","url":null,"abstract":"<p><strong>Introduction: </strong>Myocardial infarction (MI) is a complex clinical syndrome that significantly influences long-term outcomes through its effects on myocardial remodeling, heart failure progression, and mortality. Despite extensive research, there is still no consensus regarding optimal biomarkers for risk stratification of MI patients in terms of long-term outcomes.</p><p><strong>Aim: </strong>The study aimed to assess neutrophil-to-lymphocyte ratio (NLR) and evaluate the association between this ratio and long-term clinical and echocardiographic outcomes in patients hospitalized for MI.</p><p><strong>Material and methods: </strong>A total of 412 patients hospitalized for MI between 2016 and 2019 were screened. Demographic data, baseline clinical characteristics, typical biochemical parameters, and angiographic and echocardiographic findings were analyzed. Patients underwent long-term clinical and echocardiographic follow-up.</p><p><strong>Results: </strong>NLR correlated negatively with both baseline and follow-up left ventricular ejection fraction (LVEF) (<i>r</i> = -0.214; <i>p</i> = 0.043 and <i>r</i> = -0.3; <i>p</i> < 0.001, respectively). In regression analysis, NLR was a significant predictor of long-term reduced LVEF (defined as a value < 40%) (OR = 4.01; <i>p</i> < 0.001) as well as all-cause mortality (OR = 1.16; <i>p</i> = 0.008). In receiver operating characteristic (ROC) analysis, NLR demonstrated significant predictive value for mortality (AUC = 0.65; <i>p</i> = 0.04) with an optimal cut-off point of 8.7 (Youden index = 0.4). Kaplan-Meier analysis revealed that patients with NLR > 8.7 had significantly poorer survival compared to those with lower NLR values (<i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>Elevated NLR was associated with poorer left ventricular function and increased mortality in patients after MI during long-term observation.</p>","PeriodicalId":49678,"journal":{"name":"Postepy W Kardiologii Interwencyjnej","volume":"21 2","pages":"171-177"},"PeriodicalIF":1.5,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12244347/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144627573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laser For complex coronary Artery lesion pReparatiOn: the results of the pilot FARO study. 激光用于复杂冠状动脉病变准备:FARO试验研究的结果。
IF 1.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-05-31 eCollection Date: 2025-06-01 DOI: 10.5114/aic.2025.151732
Vittorio Ambrosini, Pietro Armigliato, Antonio Colombo, Massimo Napodanno, Luca Golino

Introduction: When used by experienced operators, excimer laser coronary artery angioplasty is a well-established therapy that can be used during percutaneous coronary intervention to treat a wide range of coronary lesions including heavily calcified stenosis.

Aim: This study sought to analyze the safety and effectiveness of laser angioplasty with the Auryon laser system for the treatment of heavily calcified coronary lesions.

Material and methods: A pragmatic sample of 20 patients with heavily calcified stenosis gave informed consent to participate in the study; we evaluated patient characteristics including age, cardiovascular risk factors, angiographic data (lesion complexity, number of stenoses, chronic total occlusion), calcium arch, thrombolysis in myocardial infarction (TIMI) flow before and after revascularization, percutaneous coronary intervention (PCI) success, and acute-stent thrombosis.

Results: A total of 20 subjects (20 lesions) were enrolled. A successful result, defined as < 30% residual stenosis and TIMI 3 flow after PCI, was achieved in 95% of cases.

Conclusions: This study introduced the successful use of this innovative device to treat high calcium and complex epicardial stenosis in 20 patients. The positive impressions include the ease of use and the safety and effectiveness in the treatment of severely calcified lesions.

当由经验丰富的操作者使用时,准分子激光冠状动脉血管成形术是一种成熟的治疗方法,可用于经皮冠状动脉介入治疗广泛的冠状动脉病变,包括严重钙化的狭窄。目的:本研究旨在分析激光血管成形术与Auryon激光系统治疗严重钙化的冠状动脉病变的安全性和有效性。材料和方法:20例重度钙化狭窄患者知情同意参与研究;我们评估了患者的特征,包括年龄、心血管危险因素、血管造影数据(病变复杂性、狭窄数量、慢性全闭塞)、钙弓、血运重建前后心肌梗死(TIMI)血流溶栓、经皮冠状动脉介入治疗(PCI)成功和急性支架血栓形成。结果:共纳入20名受试者(20个病灶)。95%的病例达到了成功的结果,定义为PCI术后残余狭窄< 30%和timi3血流。结论:本研究成功应用该创新装置治疗高钙和复杂心外膜狭窄20例。积极的印象包括易于使用和治疗严重钙化病变的安全性和有效性。
{"title":"Laser For complex coronary Artery lesion pReparatiOn: the results of the pilot FARO study.","authors":"Vittorio Ambrosini, Pietro Armigliato, Antonio Colombo, Massimo Napodanno, Luca Golino","doi":"10.5114/aic.2025.151732","DOIUrl":"10.5114/aic.2025.151732","url":null,"abstract":"<p><strong>Introduction: </strong>When used by experienced operators, excimer laser coronary artery angioplasty is a well-established therapy that can be used during percutaneous coronary intervention to treat a wide range of coronary lesions including heavily calcified stenosis.</p><p><strong>Aim: </strong>This study sought to analyze the safety and effectiveness of laser angioplasty with the Auryon laser system for the treatment of heavily calcified coronary lesions.</p><p><strong>Material and methods: </strong>A pragmatic sample of 20 patients with heavily calcified stenosis gave informed consent to participate in the study; we evaluated patient characteristics including age, cardiovascular risk factors, angiographic data (lesion complexity, number of stenoses, chronic total occlusion), calcium arch, thrombolysis in myocardial infarction (TIMI) flow before and after revascularization, percutaneous coronary intervention (PCI) success, and acute-stent thrombosis.</p><p><strong>Results: </strong>A total of 20 subjects (20 lesions) were enrolled. A successful result, defined as < 30% residual stenosis and TIMI 3 flow after PCI, was achieved in 95% of cases.</p><p><strong>Conclusions: </strong>This study introduced the successful use of this innovative device to treat high calcium and complex epicardial stenosis in 20 patients. The positive impressions include the ease of use and the safety and effectiveness in the treatment of severely calcified lesions.</p>","PeriodicalId":49678,"journal":{"name":"Postepy W Kardiologii Interwencyjnej","volume":"21 2","pages":"185-190"},"PeriodicalIF":1.5,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12244346/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144627572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound-guided revascularization of radial artery occlusion after transradial coronary catheterization. 超声引导下经桡动脉冠状动脉置管术后桡动脉闭塞的血运重建。
IF 1.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-05-31 eCollection Date: 2025-06-01 DOI: 10.5114/aic.2025.151723
Adam Łukasz Roszkowski, Paweł Lewandowski, Paweł Maciejewski, Tomasz Słomski, Andrzej Budaj, Bogumił Ramotowski
{"title":"Ultrasound-guided revascularization of radial artery occlusion after transradial coronary catheterization.","authors":"Adam Łukasz Roszkowski, Paweł Lewandowski, Paweł Maciejewski, Tomasz Słomski, Andrzej Budaj, Bogumił Ramotowski","doi":"10.5114/aic.2025.151723","DOIUrl":"10.5114/aic.2025.151723","url":null,"abstract":"","PeriodicalId":49678,"journal":{"name":"Postepy W Kardiologii Interwencyjnej","volume":"21 2","pages":"280-281"},"PeriodicalIF":1.5,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12244372/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144627585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HydroDynamic contrast recanalization (HDR): a new weapon against an old enemy: a case study describing a novel chronic total occlusion treatment technique. 流体动力对比再通术(HDR):对抗老敌人的新武器:一种描述慢性全闭塞治疗新技术的案例研究。
IF 1.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-05-30 eCollection Date: 2025-06-01 DOI: 10.5114/aic.2025.151698
Jakub Drozd, Wojciech Kula, Mateusz Drozd, Aleksandra Kozłowska
{"title":"HydroDynamic contrast recanalization (HDR): a new weapon against an old enemy: a case study describing a novel chronic total occlusion treatment technique.","authors":"Jakub Drozd, Wojciech Kula, Mateusz Drozd, Aleksandra Kozłowska","doi":"10.5114/aic.2025.151698","DOIUrl":"10.5114/aic.2025.151698","url":null,"abstract":"","PeriodicalId":49678,"journal":{"name":"Postepy W Kardiologii Interwencyjnej","volume":"21 2","pages":"255-258"},"PeriodicalIF":1.5,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12244371/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144627568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endovascular treatment of endoleak type IIIc after branched endovascular abdominal aortic aneurysm repair (BEVAR) improved hemodynamic state of patients with recurrent flash pulmonary edema. 分支性腹主动脉瘤修复术(BEVAR)后血管内治疗IIIc型内漏可改善复发性闪发性肺水肿患者的血流动力学状态。
IF 1.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-05-30 eCollection Date: 2025-06-01 DOI: 10.5114/aic.2025.152132
Artur Mieczkowski, Marcin Wasielewski, Łukasz Wołowiec, Grzegorz Grześk, Jacek Budzyński
{"title":"Endovascular treatment of endoleak type IIIc after branched endovascular abdominal aortic aneurysm repair (BEVAR) improved hemodynamic state of patients with recurrent flash pulmonary edema.","authors":"Artur Mieczkowski, Marcin Wasielewski, Łukasz Wołowiec, Grzegorz Grześk, Jacek Budzyński","doi":"10.5114/aic.2025.152132","DOIUrl":"10.5114/aic.2025.152132","url":null,"abstract":"","PeriodicalId":49678,"journal":{"name":"Postepy W Kardiologii Interwencyjnej","volume":"21 2","pages":"284-285"},"PeriodicalIF":1.5,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12244361/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144627564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intensification of in-hospital rehabilitation in elective post-coronary artery bypass grafting patients: both safe and effective. 加强选择性冠状动脉旁路移植术后患者的住院康复:既安全又有效。
IF 1.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-05-30 eCollection Date: 2025-06-01 DOI: 10.5114/aic.2025.151697
Daniel Karaszewski, Romuald Cichoń, Mariusz Kuśmierczyk, Mikołaj Marszałek, Radosław Wilimski

Introduction: New standards for cardiac rehabilitation are currently being established worldwide.

Aim: To evaluate the effectiveness of in-hospital rehabilitation models in patients after coronary artery bypass grafting (CABG).

Material and methods: One hundred men with stable coronary artery disease were randomly assigned to two groups: standard model (SM) and intense model (IM). Subjects then underwent CABG and were rehabilitated according to the assigned model. Effects were verified by the 6-minute walk test (6MWT), which was performed before and after the intervention.

Results: In the initial 6MWT, subjects in the SM group achieved a higher SpO2 (Me: SM = 97%, 98%; IM = 96%, 97%). In the final 6MWT, subjects in the IM group achieved a higher SpO2 (Me: SM = 96%, 97%; IM = 97%, 98%), a lower initial HR (Me: SM = 84; IM = 78) and a lower post-exercise HR (Me: SM = 92.5; IM = 84.5), a longer distance covered (Me: SM = 312 m; IM = 359 m), a lower fatigue (Me: SM = 3; IM = 1) and a shorter hospitalization time. Group differences between initial and final 6MWT; In IM: SBP and SpO2 in the initial 6MWT were higher than in the final 6MWT, HR in the initial 6MWT was lower than in the final 6MWT, distance travelled in the initial 6MWT was longer than in the final 6MWT, reported fatigue in the initial 6MWT was lower than in the final 6MWT. In IM: SBP in the initial 6MWT was higher than in the final 6MWT, SpO2 and HR in the initial 6MWT were lower than in the final 6MWT.

Conclusions: The intense model showed a more favorable effect on the physical and functional status. Increasing the load, extending the duration of training sessions, and expanding the range of functionality are safe.

导言:心脏康复的新标准目前正在世界范围内建立。目的:评价冠状动脉旁路移植术(CABG)术后住院康复模式的有效性。材料与方法:将100例稳定期冠心病患者随机分为标准模型组(SM)和高强度模型组(IM)。然后,受试者接受冠状动脉搭桥,并根据指定的模型进行康复。通过干预前后6分钟步行测试(6MWT)验证效果。结果:在最初的6MWT中,SM组获得了更高的SpO2 (Me: SM = 97%, 98%;Im = 96%, 97%)。在最后的6MWT中,IM组获得了更高的SpO2 (Me: SM = 96%, 97%;IM = 97%, 98%),较低的初始HR (Me: SM = 84;IM = 78)和较低的运动后HR (Me: SM = 92.5;IM = 84.5),覆盖距离较长(Me: SM = 312 m;IM = 359 m),较低的疲劳(Me: SM = 3;IM = 1),住院时间较短。初始和最终6MWT的组间差异;在IM中:初始6MWT的SBP和SpO2高于最终6MWT,初始6MWT的HR低于最终6MWT,初始6MWT的行驶距离比最终6MWT长,初始6MWT报告的疲劳低于最终6MWT。在IM中:初始6MWT的SBP高于最终6MWT,初始6MWT的SpO2和HR低于最终6MWT。结论:高强度模型对大鼠的身体和功能状态有较好的影响。增加负荷,延长训练时间,扩大功能范围是安全的。
{"title":"Intensification of in-hospital rehabilitation in elective post-coronary artery bypass grafting patients: both safe and effective.","authors":"Daniel Karaszewski, Romuald Cichoń, Mariusz Kuśmierczyk, Mikołaj Marszałek, Radosław Wilimski","doi":"10.5114/aic.2025.151697","DOIUrl":"10.5114/aic.2025.151697","url":null,"abstract":"<p><strong>Introduction: </strong>New standards for cardiac rehabilitation are currently being established worldwide.</p><p><strong>Aim: </strong>To evaluate the effectiveness of in-hospital rehabilitation models in patients after coronary artery bypass grafting (CABG).</p><p><strong>Material and methods: </strong>One hundred men with stable coronary artery disease were randomly assigned to two groups: standard model (SM) and intense model (IM). Subjects then underwent CABG and were rehabilitated according to the assigned model. Effects were verified by the 6-minute walk test (6MWT), which was performed before and after the intervention.</p><p><strong>Results: </strong>In the initial 6MWT, subjects in the SM group achieved a higher SpO<sub>2</sub> (Me: SM = 97%, 98%; IM = 96%, 97%). In the final 6MWT, subjects in the IM group achieved a higher SpO<sub>2</sub> (Me: SM = 96%, 97%; IM = 97%, 98%), a lower initial HR (Me: SM = 84; IM = 78) and a lower post-exercise HR (Me: SM = 92.5; IM = 84.5), a longer distance covered (Me: SM = 312 m; IM = 359 m), a lower fatigue (Me: SM = 3; IM = 1) and a shorter hospitalization time. Group differences between initial and final 6MWT; In IM: SBP and SpO<sub>2</sub> in the initial 6MWT were higher than in the final 6MWT, HR in the initial 6MWT was lower than in the final 6MWT, distance travelled in the initial 6MWT was longer than in the final 6MWT, reported fatigue in the initial 6MWT was lower than in the final 6MWT. In IM: SBP in the initial 6MWT was higher than in the final 6MWT, SpO<sub>2</sub> and HR in the initial 6MWT were lower than in the final 6MWT.</p><p><strong>Conclusions: </strong>The intense model showed a more favorable effect on the physical and functional status. Increasing the load, extending the duration of training sessions, and expanding the range of functionality are safe.</p>","PeriodicalId":49678,"journal":{"name":"Postepy W Kardiologii Interwencyjnej","volume":"21 2","pages":"229-236"},"PeriodicalIF":1.5,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12244374/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144627571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful interventional treatment of chemotherapy port-related thrombosis in a patient with colorectal adenocarcinoma. 1例结直肠腺癌化疗口相关血栓的成功介入治疗。
IF 1.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-05-30 eCollection Date: 2025-06-01 DOI: 10.5114/aic.2025.151700
Ida Szataniak, Agata Krawczyk-Ożóg, Danuta Sorysz, Artur Dziewierz, Stanisław Bartuś, Barbara Zdzierak
{"title":"Successful interventional treatment of chemotherapy port-related thrombosis in a patient with colorectal adenocarcinoma.","authors":"Ida Szataniak, Agata Krawczyk-Ożóg, Danuta Sorysz, Artur Dziewierz, Stanisław Bartuś, Barbara Zdzierak","doi":"10.5114/aic.2025.151700","DOIUrl":"10.5114/aic.2025.151700","url":null,"abstract":"","PeriodicalId":49678,"journal":{"name":"Postepy W Kardiologii Interwencyjnej","volume":"21 2","pages":"286-288"},"PeriodicalIF":1.5,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12244348/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144627580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A single vein approach for percutaneous self-expanding valve implantation: report of two cases. 单静脉入路经皮自扩张瓣膜植入术2例报告。
IF 1.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-05-30 eCollection Date: 2025-06-01 DOI: 10.5114/aic.2025.151702
Maksym Lazu, Judyta Szeliga, Reinhardt Becht, Sebastian Góreczny
{"title":"A single vein approach for percutaneous self-expanding valve implantation: report of two cases.","authors":"Maksym Lazu, Judyta Szeliga, Reinhardt Becht, Sebastian Góreczny","doi":"10.5114/aic.2025.151702","DOIUrl":"10.5114/aic.2025.151702","url":null,"abstract":"","PeriodicalId":49678,"journal":{"name":"Postepy W Kardiologii Interwencyjnej","volume":"21 2","pages":"262-266"},"PeriodicalIF":1.5,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12244356/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144627558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atrial fibrillation following shockwave intravascular lithotripsy. 冲击波血管内碎石术后心房颤动。
IF 1.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-05-30 eCollection Date: 2025-06-01 DOI: 10.5114/aic.2025.151701
Barbara Zdzierak, Piotr Jarosz, Łukasz Rzeszutko, Wojciech Zasada, Stanisław Bartuś, Artur Dziewierz
{"title":"Atrial fibrillation following shockwave intravascular lithotripsy.","authors":"Barbara Zdzierak, Piotr Jarosz, Łukasz Rzeszutko, Wojciech Zasada, Stanisław Bartuś, Artur Dziewierz","doi":"10.5114/aic.2025.151701","DOIUrl":"10.5114/aic.2025.151701","url":null,"abstract":"","PeriodicalId":49678,"journal":{"name":"Postepy W Kardiologii Interwencyjnej","volume":"21 2","pages":"274-277"},"PeriodicalIF":1.5,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12244353/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144627560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Postepy W Kardiologii Interwencyjnej
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1